Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

145 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Limitations of probit plots in pharmacogenetics: requirement of genetic analyses to test hypotheses based on graphical methods.
Vesell ES, Gaylor DW. Vesell ES, et al. Among authors: gaylor dw. Pharmacogenetics. 1995 Feb;5(1):18-23. doi: 10.1097/00008571-199502000-00002. Pharmacogenetics. 1995. PMID: 7773299 No abstract available.
On the correlation coefficient between the TD50 and the MTD.
Razzaghi M, Gaylor DW. Razzaghi M, et al. Among authors: gaylor dw. Risk Anal. 1996 Feb;16(1):107-13. Risk Anal. 1996. PMID: 8868225
On interspecies correlations of carcinogenic potencies.
Kodell RL, Basu AP, Gaylor DW. Kodell RL, et al. Among authors: gaylor dw. J Toxicol Environ Health. 1996 Jun 28;48(3):231-7. doi: 10.1080/009841096161302. J Toxicol Environ Health. 1996. PMID: 8656447
Issues in qualitative and quantitative risk analysis for developmental toxicology.
Kimmel CA, Gaylor DW. Kimmel CA, et al. Among authors: gaylor dw. Risk Anal. 1988 Mar;8(1):15-20. doi: 10.1111/j.1539-6924.1988.tb01149.x. Risk Anal. 1988. PMID: 3375503
A comparison of microbial dose-response models fitted to human data.
Moon H, Chen JJ, Gaylor DW, Kodell RL. Moon H, et al. Among authors: gaylor dw. Regul Toxicol Pharmacol. 2004 Oct;40(2):177-84. doi: 10.1016/j.yrtph.2004.07.003. Regul Toxicol Pharmacol. 2004. PMID: 15450720
Procedures for calculating benchmark doses for health risk assessment.
Gaylor D, Ryan L, Krewski D, Zhu Y. Gaylor D, et al. Regul Toxicol Pharmacol. 1998 Oct;28(2):150-64. doi: 10.1006/rtph.1998.1247. Regul Toxicol Pharmacol. 1998. PMID: 9927564 Review.
New directions for predicting carcinogenesis.
Schwetz B, Gaylor D. Schwetz B, et al. Mol Carcinog. 1997 Nov;20(3):275-9. doi: 10.1002/(sici)1098-2744(199711)20:3<275::aid-mc3>;2-k. Mol Carcinog. 1997. PMID: 9397187 Review.
Alternative tests: carcinogenesis as an example.
Schwetz B, Gaylor D. Schwetz B, et al. Environ Health Perspect. 1998 Apr;106 Suppl 2(Suppl 2):467-71. doi: 10.1289/ehp.98106467. Environ Health Perspect. 1998. PMID: 9599693 Free PMC article.
Neuroprotection or neurotoxicity: impact of discontinuous dose-response curves on risk assessment.
Slikker W Jr, Duhart H, Gaylor D, Imam S. Slikker W Jr, et al. Ann N Y Acad Sci. 2003 May;993:158; discussion 159-60. Ann N Y Acad Sci. 2003. PMID: 12853308 No abstract available.
A mechanistic approach to modelling the risk of liver tumours in mice exposed to fumonisin B1 in the diet.
Kodell RL, Young JF, Delongchamp RR, Turturro A, Chen JJ, Gaylor DW, Howard PC, Zheng Q. Kodell RL, et al. Among authors: gaylor dw. Food Addit Contam. 2001 Mar;18(3):237-53. doi: 10.1080/02652030010021972. Food Addit Contam. 2001. PMID: 11304033
145 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page